Nukkleus Inc. (NASDAQ:NUKK – Get Free Report) major shareholder Sc Capital Ii Sponsor Llc purchased 255,000 shares of the company’s stock in a transaction dated Friday, November 28th. The stock was purchased at an average price of $10.00 per share, with a total value of $2,550,000.00. Following the completion of the purchase, the insider directly owned 255,000 shares in the company, valued at $2,550,000. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Nukkleus Stock Up 10.1%
Shares of NUKK stock opened at $6.65 on Thursday. Nukkleus Inc. has a twelve month low of $1.34 and a twelve month high of $78.32. The stock’s fifty day simple moving average is $7.12 and its 200 day simple moving average is $8.20. The firm has a market capitalization of $110.72 million, a P/E ratio of 0.41 and a beta of -6.75.
Nukkleus (NASDAQ:NUKK – Get Free Report) last posted its earnings results on Friday, November 14th. The company reported ($2.02) EPS for the quarter.
Institutional Trading of Nukkleus
Analyst Upgrades and Downgrades
Several research firms recently commented on NUKK. Wall Street Zen upgraded shares of Nukkleus from a “sell” rating to a “hold” rating in a research report on Sunday, November 23rd. Weiss Ratings reiterated a “sell (d)” rating on shares of Nukkleus in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Read Our Latest Stock Report on Nukkleus
Nukkleus Company Profile
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Recommended Stories
- Five stocks we like better than Nukkleus
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- What is the Australian Securities Exchange (ASX)
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- ETF Screener: Uses and Step-by-Step Guide
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
